Announcements Trials
Browse Landscape

Phase

Phase 2 19Phase NA 4Phase 1 3Phase 2/3 2Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Genitourinary 1Classical hematology 1Breast 1

Conditions

Myelodysplastic Syndromes 8Leukemia, Myeloid, Acute 8Leukemia, Lymphocytic, Chronic, B-Cell 7Leukemia 7Lymphoma, Non-Hodgkin 5Hodgkin Disease 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Multiple Myeloma 4Lymphoma 4Myeloproliferative Disorders 3Lymphoma, Mantle-Cell 3Lymphoma, Follicular 3Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Congenital Abnormalities 3Waldenstrom Macroglobulinemia 2Thrombocythemia, Essential 2Primary Myelofibrosis 2Polycythemia Vera 2Pdgfra-Associated Chronic Eosinophilic Leukemia 2Neoplasms, Plasma Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Prolymphocytic 2Leukemia, Neutrophilic, Chronic 2Leukemia, Myeloid, Accelerated Phase 2Graft vs Host Disease 2Burkitt Lymphoma 2Blast Crisis 2

Interventions

Cyclophosphamide 7fludarabine phosphate 6Peripheral Blood Stem Cell Transplantation 6Mycophenolic Acid 5Whole-Body Irradiation 4Filgrastim 4fludarabine 3Cytarabine 3Cyclosporine 3Cord Blood Stem Cell Transplantation 3Busulfan 3Transplantation 2Topotecan 2Tacrolimus 2Gene Expression Profiling 2Flow Cytometry 2Etoposide 2Cytogenetic Analysis 2Bone Marrow Transplantation 2Azacitidine 2tipifarnib 1sargramostim 1pegylated granulocyte colony-stimulating factor 1montanide ISA 51 1decitabine and cedazuridine drug combination 1aldesleukin 1X-Rays 1Vorinostat 1Vitamin E 1Tretinoin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Anemia, Refractory, with Excess of Blasts × Antilymphocyte Serum × Clear all
NCT00365287 2017-11-29

Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer

Masonic Cancer Center, University of Minnesota

Phase 1/2 Completed
148 enrolled
BreastClassical hematologyGenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Congenital Abnormalities, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Breast Neoplasms, Burkitt Lymphoma, Carcinoma, Renal Cell, Hodgkin Disease, Kidney Neoplasms, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡